Dietary Supplement
Testosterone boosting supplement for Testosterone
Recruiting0 awards2 criteria
Toronto, Ontario
The purpose of this study is to determine whether a proprietary 'testosterone-boosting' supplement, when used as recommended by the manufacturer, results in an increase in testosterone levels as measured by a salivary free testosterone assay.
Androgen
Testosterone cream for Primary Ovarian Insufficiency
Recruiting2 awardsPhase 1 & 2
New York, New York
This trial will compare the effects of testosterone cream to placebo on measures of ovarian reserve, oocyte quality, embryo quality, and pregnancy rates in women with diminished ovarian reserve who have low serum testosterone and free testosterone levels after completing six weeks of DHEA supplementation.
Medications for Cerebral Blood Flow Regulation
Recruiting0 awardsPhase < 1
Madison, Wisconsin
This trial is testing whether men and women have different ways of controlling blood flow to the brain. The stress is low oxygen or high carbon dioxide. The study will use medicine infusions during stress and MRI to measure brain blood flow.
Popular Filters
Trials With No Placebo
Corticosteroid
Testosterone for Insulin Resistance
Recruiting3 awards3 criteria
San Diego, California
This trial is testing different treatments involving testosterone to see if they can help build muscle, reduce fat, and improve how the body handles sugar. Researchers believe that testosterone will improve body composition and insulin sensitivity, with different effects depending on the additional treatments used. Testosterone therapy has been shown to increase muscle mass, reduce fat, and improve insulin sensitivity in various studies.
Hormone Therapy
Deslorelin + Hormone Therapy for Breast Cancer Prevention in High-Risk Women
Recruiting1 awardPhase 2
Duarte, California
This trial is studying deslorelin combined with low-dose add-back estradiol and testosterone to see how well it works in preventing breast cancer in premenopausal women who are at high risk for this disease.
Hormone Therapy
Sequential Testosterone + Enzalutamide for Prostate Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial tests if alternating high doses of testosterone and enzalutamide can help men with advanced prostate cancer better than just using enzalutamide alone. It targets men whose cancer has continued to progress despite standard treatments. The treatment works by first disrupting the cancer cells with high-dose testosterone, then blocking any remaining cancer cells from using testosterone with enzalutamide. Enzalutamide has been associated with improved overall survival in men with advanced prostate cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.